Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization

Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization

Bibliographic Details
Main Authors:	Mohammad Saeid Rezaee-Zavareh, Naomy Kim, Ju Dong Yang
Format:	Article
Language:	English
Published:	Korean Association for the Study of the Liver 2024-04-01
Series:	Clinical and Molecular Hepatology
Subjects:	liver diseases hepatocellular carcinoma complement system proteins mendelian randomization drug repositioning
Online Access:	http://e-cmh.org/upload/pdf/cmh-2024-0116.pdf

Similar Items

Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets
by: Yingzhou Shi, et al.
Published: (2024-01-01)

Associations of non‐alcoholic fatty liver disease and cirrhosis with liver cancer in European and East Asian populations: A Mendelian randomization study
by: Yunyang Deng, et al.
Published: (2024-01-01)

Liver function indicators and risk of hepatocellular carcinoma: a bidirectional mendelian randomization study
by: Shanshan Qin, et al.
Published: (2024-01-01)

Lipids, cholesterols, statins and liver cancer: a Mendelian randomization study
by: Zicheng Liang, et al.
Published: (2023-09-01)

Editorial: New insights into the role of complement system in liver diseases
by: Zhenya Guo, et al.
Published: (2023-09-01)

Identifying actionable druggable targets for breast cancer: Mendelian randomization and population-based analysesResearch in context
by: Naiqi Zhang, et al.
Published: (2023-12-01)

Causal associations between liver traits and Colorectal cancer: a Mendelian randomization study
by: Ying Ni, et al.
Published: (2023-12-01)

Causal effects of gut microbiome on autoimmune liver disease: a two-sample Mendelian randomization study
by: Yugang Fu, et al.
Published: (2023-10-01)

Low-density lipoprotein cholesterol and risk of hepatocellular carcinoma: a Mendelian randomization and mediation analysis
by: Jiali Cao, et al.
Published: (2023-07-01)

Causal relationships between telomere length and liver disease: a Mendelian randomization study
by: Shuangjing Zhu, et al.
Published: (2023-07-01)

Causal effects from nonalcoholic fatty liver disease on cholelithiasis: A mendelian randomization study
by: Yin‐Shi Su, et al.
Published: (2024-03-01)

Associations between type 2 diabetes mellitus and chronic liver diseases: evidence from a Mendelian randomization study in Europeans and East Asians
by: Yue Zhao, et al.
Published: (2024-03-01)

Lifestyle factors, glycemic traits, and lipoprotein traits and risk of liver cancer: a Mendelian randomization analysis
by: Honglu Zhang, et al.
Published: (2024-04-01)

Journey of Natural Killer Cells and their Role in Liver Diseases
by: Archana Buch, et al.
Published: (2022-04-01)

Depression and hepatobiliary diseases: a bidirectional Mendelian randomization study
by: Yu Kong, et al.
Published: (2024-03-01)

An update on the role of complement in hepatocellular carcinoma
by: Zhijie Xiao, et al.
Published: (2022-10-01)

Association Between Psoriasis and Non-Alcoholic Fatty Liver Disease: A Two-Sample Mendelian Randomization Study
by: Li H, et al.
Published: (2023-11-01)

Genetic effects of iron levels on liver injury and risk of liver diseases: A two-sample Mendelian randomization analysis
by: Kai Wang, et al.
Published: (2022-09-01)

Genetic evidence of the causal relationship between chronic liver diseases and musculoskeletal disorders
by: Zhengjie Lu, et al.
Published: (2024-02-01)

Hypothyroidism has a protective causal association with hepatocellular carcinoma: A two-sample Mendelian randomization study
by: Likui Lu, et al.
Published: (2022-09-01)

Identifying Proteins and Amino Acids Associated with Liver Cancer Risk: A Study Utilizing Mendelian Randomization and Bulk RNA Sequencing Analysis
by: Chi Ma, et al.
Published: (2024-02-01)

Association between telomere length and hepatocellular carcinoma risk: A Mendelian randomization study
by: Chenglei Yang, et al.
Published: (2023-04-01)

Comprehensive analysis of complement-associated molecular features in hepatocellular carcinoma
by: Huang Run, et al.
Published: (2022-08-01)

Causal effects of non-alcoholic fatty liver disease on osteoporosis: a Mendelian randomization study
by: Yue Zhou, et al.
Published: (2023-12-01)

Vitamin D and Nonalcoholic Fatty Liver Disease: Bi-directional Mendelian Randomization Analysis
by: Ningjian Wang, et al.
Published: (2018-02-01)

Drug repositioning and ovarian cancer, a study based on Mendelian randomisation analysis
by: Lin Zhu, et al.
Published: (2024-04-01)

Dissecting the association between gut microbiota and liver cancer in European and East Asian populations using Mendelian randomization analysis
by: Hua Jiang, et al.
Published: (2023-09-01)

The role of complement in the clinical course of hepatocellular carcinoma
by: Xinye Qian, et al.
Published: (2022-03-01)

“Complimenting the Complement”: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma
by: Astha Malik, et al.
Published: (2021-02-01)

Systemic inflammatory regulators and risk of acute-on-chronic liver failure: A bidirectional mendelian-randomization study
by: Shengnan Wang, et al.
Published: (2023-01-01)

Causal relationship between the immune cells and ankylosing spondylitis: univariable, bidirectional, and multivariable Mendelian randomization
by: Chaofan Qin, et al.
Published: (2024-04-01)

Non-alcoholic fatty liver disease and gestational diabetes mellitus: a bidirectional two-sample mendelian randomization study
by: Ben-Gang Zhou, et al.
Published: (2024-03-01)

Chimeric Livers: Interspecies Blastocyst Complementation and Xenotransplantation for End-Stage Liver Disease
by: Blake MJ, et al.
Published: (2024-02-01)

Does Cannabis Intake Protect Against Non-alcoholic Fatty Liver Disease? A Two-Sample Mendelian Randomization Study
by: Xiaokun Wang, et al.
Published: (2020-08-01)

Causal association between arsenic metabolism and non-alcoholic fatty liver disease based on Mendelian randomization
by: Yuenan LIU, et al.
Published: (2023-12-01)

Causal associations between inflammatory factors and liver cancer
by: L. Wang, et al.
Published: (2023-09-01)

Nonalcoholic fatty liver disease and type 2 diabetes: an observational and Mendelian randomization study
by: Yuetian Yu, et al.
Published: (2023-05-01)

Circulating inflammatory cytokines in relation to the risk of renal cell carcinoma: A gender‐specific two‐sample Mendelian randomization study
by: Shuixiang Tao, et al.
Published: (2023-11-01)

Impact of waiting time on post-transplant survival for recipients with hepatocellular carcinoma: A natural experiment randomized by blood group
by: Berend R Beumer, et al.
Published: (2023-02-01)

Role of Inflammatory Factors in Mediating the Effect of Lipids on Nonalcoholic Fatty Liver Disease: A Two-Step, Multivariable Mendelian Randomization Study
by: Junhong Chen, et al.
Published: (2022-10-01)